<DOC>
	<DOCNO>NCT01870427</DOCNO>
	<brief_summary>The purpose study determine effect Intravitreal Aflibercept Injection ( IAI ) previously treat Central Retinal Vein Occlusions ( CRVOs ) Anti-VEGF agent .</brief_summary>
	<brief_title>NEWTON : Aflibercept Injection Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions</brief_title>
	<detailed_description>This prospective , open-label , single-center , nonrandomized , investigator-sponsored clinical study seek investigate visual outcome treat extend dose regimen intravitreal aflibercept injection macular edema follow CRVO . All patient receive IAI 2 mg baseline Week 4 . If pre-defined extension criterion meet 4-week visit , follow visit , patient receive mandate treatment , next visit extend two week . If extension criterion meet follow-up visit , treatment interval continue reduce 1 week . If criterion still meet despite treatment reduce interval , treatment administer usual follow interval continue reduce 1 week criterion meet 4-week interval reach . Treatment IAI render every visit .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<criteria>Patients age 18 documented history centerinvolved macular edema secondary CRVO . Patients must receive treatment least 6 month baseline , 3 initial loading dos , evidence recurrence edema extend beyond 4 week . Protocol refract ETDRS BCVA 20/25 20/320 ( 7324 letter ) . Willing able comply clinic visit studyrelated procedure . Provide sign informed consent . Prior panretinal macular laser photocoagulation Previous use intraocular corticosteroid use periocular corticosteroid within 3 month prior day 1 Prior treatment systemic antiVEGF agent Presence iris neovascularization Vitreous hemorrhage Study Eye Traction retinal detachment , preretinal fibrosis involve macula Diabetic macular edema diabetic retinopathy , define eye diabetic patient 1 microaneurysm outside area vein occlusion . Infectious blepharitis , keratitis , scleritis , conjunctivitis . Active intraocular inflammation ( grade trace ) study eye , history idiopathic autoimmuneassociated uveitis either eye . Uncontrolled glaucoma study eye ( defined intraocular pressure equal great 30mmHg despite treatment antiglaucoma medication ) Concurrent eye disease study eye could compromise visual acuity ( e.g . advanced glaucoma , agerelated macular degeneration , etc ) Any concurrent intraocular condition study eye ( e.g . glaucoma ) , opinion investigator , could either require medical surgical intervention 52 week study period prevent treat visual loss might result condition . Pregnant breastfeed woman Sexually active men* woman childbearing potential** unwilling practice adequate contraception study ( adequate contraceptive measure include stable use oral contraceptive prescription pharmaceutical contraceptive 2 menstrual cycle prior screen ; intrauterine device [ IUD ] ; bilateral tubal ligation ; vasectomy ; condom plus , contraceptive sponge , foam jelly , diaphragm ) *Contraception require men document vasectomy . **Postmenopausal woman must amenorrheic least 12 month order consider child bear potential . Pregnancy test contraception require woman document hysterectomy tubal ligation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Macular Edema</keyword>
	<keyword>Central Retinal Vein Occlusion</keyword>
	<keyword>CRVO</keyword>
	<keyword>Aflibercept</keyword>
	<keyword>VEGF Trap-Eye</keyword>
	<keyword>Eylea</keyword>
	<keyword>Ranibizumab</keyword>
	<keyword>Bevacizumab</keyword>
</DOC>